I. Introduction 99m
Tc-methylene diphosphonate (MDP) has been clinically used for skeletal imaging for many years. The most common use is a screening test for the detection of bone metastases from malignant tumors. Patients with malignant tumors in the genitourinary tract are likely to have impaired renal function. Furthermore, damage to the kidneys is caused by chemotherapy and/or radiation therapy when the kidneys are included in the radiation field. Therefore, the estimation of renal function as well as the detection of bone metastases is inevitable in these patients.
Renal function has been estimated with Tc-DTPA is a chelating agent which was introduced into renal nuclear medicine in 1970. Tc-DTPA is the least expensive renal radiopharmaceutical. It is cleared by the glomerulus and can be used to measure glomerular filtration rate (GFR) 
II. Materials And Methods

Patients:
A total of 13 adult patients (1 male, 12 females) with malignant tumors were enrolled. Their ages ranged from 37 to 65 years (mean 51±14), Heights ranged from 146 to 175 cm (mean 160±14) and Weights ranged from 40 to 91 Kgm (mean 65±25). Excluding a patient with perirenal abscess or had malignant tumors in the genitourinary tract. All the patients underwent both radionuclide studies with Tc-DTPA was prepared according to the manufacturer's instructions with the kits in radioisptope laboratory in Nuclear Medicine Department of Oncology and Nuclear Medicine, Assiut University Hospitals, Egypt. Using a commercially available kits. Counts in pre-injection and post-injection syringes were measured for 60 seconds at 30 cm from the Gamma-Camera (MARCONI AXIS2, VT TECHNOLOGY INC, CLEVELAND, OHIO 44143, USA), to determine the net amounts of activity injected. Each patient was hydrated with 200 ml of water 30 minutes before the examination. Renography was carried out with the patient in a supine position with the gamma-camera detector placed under the patient's bed. Rapid injection of 5 mCi of 99m Tc-DTPA was given through an end welling butterfly needle in an antecubital vein and was followed by infusion of 10 ml of normal saline. Immediately after tracer arrival within the kidneys, data acquisition was performed for 31 minutes (1 sec per frame for 60 sec and 15 sec per frame for 1800 sec) with a scintillation camera equipped with a general purpose, low energy parallel hole type collimator. A 20% energy window was centered around the 140 keV photopeak. With a 64 x 64 matrix on a computer processing system (MARCONI MEDICAL SYSTEMS, ODYSSEY FX 810, COMPAQ), serial interval dynamic images were recorded on radiographic film. Tc-MDP (3 hour image). Images were comparatively interpreted as to kidney size, position, tracer activity relative to soft tissue and bone uptake, uniformity of tracer distribution, degree of radioisotope retention, and pelvicalyceal dilation as well as whole body skeleton by two experienced nuclear physicians.
Skeletal and Renal Imaging with
Data Analysis:
A region of interest (ROI) was placed around each kidney, and a semilunar background region was placed inferior to each kidney. After background subtraction, time-activity curves (renograms) were generated for both kidneys. With a renogram GFR of each kidney,Split (Differential GFR), T peak (time from injection to time of maximum count rate), and T 1/2 (The half emptying time) were obtained.
Estimation of Total and Split GFR:
The GFR was determined by a modified Gates Tc-MDP in the ROIs from 2 to 3 minutes after tracer arrival within the kidneys.
III. Results
The GFR obtained by means of 
GFR Patterns:
Fifty-two value of GFR were obtained on (13) patients using 
IV. Discussion
Many authors have reported a number of renal abnormalities discovered incidentally on bone scintigraphy ]10[ .These abnormalities have included absent renal activity, small or displaced kidneys, urinary obstruction, focal renal parenchymal abnormalities, unilateral decrease in renal function, and asymmetric uptake. In addition, detailed views of the bladder can Tc-MDP can be affected these various conditions. In order to obtain GFR, the percent uptake of 2 to 3 minutes after the radionuclide appearance in the kidneys was used. This gives information regarding renal morphology and renal function incidental to bone scintigraphy with 
Estimation of GFR Total GFR:
Review the chart for total kidney note that there is a difference between two tracers .001) because the study course different ,they chose patients with diagnosed with hydronephrosis or underwent a therapeutic operation. But our patients selected on the basis that they do not suffer from the disease in the kidneys so that's maybe the back of this difference.
Left kidney
Review the chart for left kidney after the exclusion of points (1 & 2) note left GFR was obtained by means of 
Right kidney
Review the chart for right kidney after the exclusion of points (1 & 2) we find right GFR was obtained by means of 
Estimation of split Left split
Review the chart for left kidney without excluding any points we find left Split was obtained by means of 
Right split
Review the chart for right kidney without excluding any points we find right 
V. Conclusion
The assessment of renal function with 99m
Tc-MDP can be performed incidental to bone scintigraphy and is expected to provide useful information in monitoring renal function.
The early characteristics of renal handling of Tc-MDP determined renal differential most likely reflects differential glomular filtration rate even with a difference of the quantity of radiopharmaceuticals for tow tracers, and both kidneys were normal or abnormal. With reference to T 1/2 and T peak the results show, which was obtained significant difference between tow tracers.
